Xiaogang Ying

447 citations
10 papers · 342 indexed · h-index 5
Topics
Genetic Syndromes and Imprinting (2 papers)Cancer-related molecular mechanisms research (2 papers)Cancer-related gene regulation (2 papers)
Partner nations
ChinaUnited States

In The Last Decade

Xiaogang Ying

9 papers receiving 342 citations

Peers

Xiaogang Ying
Comparison fields: 5 of 53
  • Molecular Biology 264
  • Cancer Research 213
  • Oncology 54
  • Epidemiology 50
  • Pulmonary and Respiratory Medicine 41
Replace Rongwei Guan with:
Rongwei Guan China
Zhousan Zheng China
Jingxu Sun China
Samaneh Adelian Iran
Rongdang Fu China
Mengtao Ma China
Ahmet Arslan Türkiye
Mackenzie Thornton United States
Xian-Long Fang China
Xiaogang Ying relative to Rongwei Guan China Rongwei Guan's profile →
Citations per field
00.5×2.9×
Rongwei Guan · 1×
Citations per year

Countries citing papers authored by Xiaogang Ying

Since Specialization
Citations

This map shows the geographic impact of Xiaogang Ying's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Ying with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Ying more than expected).

Fields of papers citing papers by Xiaogang Ying

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaogang Ying. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Ying. The network helps show where Xiaogang Ying may publish in the future.

Co-authorship network of co-authors of Xiaogang Ying

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Ying. A scholar is included among the top collaborators of Xiaogang Ying based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Ying. Xiaogang Ying is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
#WorkIndexed citations
1 2
2 2
3
Propofol combined with remifentanil reduces the adverse reactions of patients undergoing laparoscopic cholecystectomies.
0
4 2
5 206
6 24
7 44
8 1
9 43
10 18

About Xiaogang Ying

Xiaogang Ying is a scholar working on Cancer Research, Anesthesiology and Pain Medicine and Immunology and Allergy, having authored 10 papers that have together received 342 indexed citations. Recurring topics across this work include Genetic Syndromes and Imprinting (2 papers), Cancer-related molecular mechanisms research (2 papers) and Cancer-related gene regulation (2 papers). The work is most often cited by research in Cancer Research (213 citations), Molecular Biology (264 citations) and Oncology (54 citations). Xiaogang Ying has collaborated with scholars based in China and United States. Frequent co-authors include Linbo Wang, Yongxia Chen, Jichun Zhou, Yunlu Jia, Hanchu Xiong, Chenyang Ye, Cong Chen, Wang Ji, Yulu Zhou and Jingjing Yang. Their work appears in journals such as Annals of Oncology, Cell Death and Disease and Journal of Hematology & Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026